The global superdisintegrants market is
expected to reach USD 487.0 million by 2025, according to a new report by Grand
View Research, Inc. Superdisintegrants help in the disintegration of tablet or
capsule content into small particles and create a greater surface area for
speedy drug release.
A number of fast disintegrating
tablet such as salbutamol sulphate, and cetirizine hydrochloride in
tablet/capsule dosage form for respiratory disorders (bronchitis, asthma, and
coughing) are formulated for pediatric and geriatric patients, due to their
difficulty or discomfort in swallowing. Superdisintegrant such as crospovidone,
croscarmellose sodium, and sodium starch glycolate are used in optimized
concentration to formulate such tablets/capsules along with different binders
such as MCC and PVP K-30.
Browse full report by Grand View
Research :
Further key findings from the study suggest:
·
The market study suggests that crospovidone
dominated the overall market in 2016. Crospovidone is completely insoluble in
water and rapidly disperses and swells in water. It has greatest rate of
swelling and surface area to volume ratio compared to other disintegrants.
Hence, these factors are contributing towards the large share of crospovidone
in 2016.
·
Others segment, which includes natural
superdisintegrants, is expected to witness highest growth rate. Factors such as
local accessibility, bio-acceptable, renewable source, eco‐friendly nature and lower prices compared to important
synthetic products, are driving the growth of the segment during the forecast
period.
·
Amongst the dosage form segments, tablets
and capsules occupied the largest share in 2016 as they are the most common and
preferred dosage forms for delivering drugs to patients.
·
The mouth-dissolving films segment is
expected to grow at the highest growth rate during the forecast period. It is
the preferred choice for patients as compared to tablets and capsules due to
greater flexibility and comfort of the former.
·
Hence, the market for disintegrants in
mouth-dissolving films would continue to grow due to quicker onset of action
for a dosage form and better convenience of administration.
·
North America dominated the regional
segment with the largest revenue share in 2016, due to number of
superdisintegrants manufacturers operating in the region and prolific research
and development initiatives
·
Asia Pacific is expected to witness
significant growth during the forecast period, owing to booming medical tourism
industry in the region and lucrative contract research outsourcing services
·
Some of the major companies operating in
this market are Ashland Global Holdings Inc., Roquette Frères S.A., FMC
Corporation, DFE Pharma, Huber Corporation, Nippon Soda Co., Ltd. The Dow
Chemical Company and BASF SE. and others.
Browse more reports of this category by Grand View
Research: http://www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has
segmented the superdisintegrants market on the basis of product, dosage form,
and region:
Product Outlook (Revenue, USD Million, 2014 - 2025)
·
Croscarmellose sodium
·
Crospovidone
·
Sodium starch glycolate
·
Ion exchange resin
·
Others
Dosage Form Outlook (Revenue, USD Million, 2014 - 2025)
·
Tablets and Capsules
·
Mouth-dissolving Films
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·
North America
o U.S.
o Canada
·
Europe
o Germany
o UK
·
Asia Pacific
o China
o Japan
·
Latin America
o Brazil
o Mexico
·
MEA
o South Africa
Access
press release by Grand View Research: http://www.grandviewresearch.com/press-release/global-superdisintegrants-market
About
Grand View Research
Grand View Research, Inc. is a U.S. based market research
and consulting company, registered in the State of California and headquartered
in San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For
more information: http://www.grandviewresearch.com